The Ink4a͞Arf locus encodes p16 Ink4a and p19 Arf and is among the most frequently mutated tumor suppressor loci in human cancer. In mice, many of these effects appear to be mediated by interactions between p19 Arf and p53, Ink4a͞Arf expression correlates with or precedes the emergence of cells expressing mutant p53. These data demonstrate that p19 Arf is an important part of the cellular defense mounted against transforming signals from the Abl oncoprotein and provide direct evidence that the p19 Arf -p53 regulatory loop plays an important role in lymphoma induction.
Tumor induction is a multistep process involving activation of oncogenes and inactivation of tumor-suppressor genes (1, 2) . One experimental system to which this paradigm applies is transformation by Abelson murine leukemia virus (Ab-MLV), an oncogenic retrovirus that encodes the v-Abl protein tyrosine kinase (3) . The virus induces mono-or oligoclonal pre-B cell tumors (4, 5) , and clonal selection also occurs in vitro. Primary pre-B cell transformants are poorly oncogenic and undergo an apoptotic crisis soon after isolation (6) (7) (8) (9) . Cells that survive are rapidly growing and highly tumorigenic (6) (7) (8) . Mutations in the Tp53 tumor-suppressor gene become evident in about half of the surviving clones as they emerge from crisis or soon thereafter (8) , and primary Ab-MLV transformants derived from Tp53 Ϫ͞Ϫ mice bypass crisis and become established rapidly (I.U., A.R., and N.R., unpublished data). Thus, p53 is one important cellular defense against malignant transformation by Ab-MLV.
p53 is regulated by multiple factors, including p19
Arf , a product of the Ink4a͞Arf locus (10) (11) (12) (13) (14) (15) . p19
Arf is part of the protective cellular response to oncogenic insults from at least two oncogenes, c-Myc and adenovirus E1A (13, 14) . p19
Arf stabilizes and activates p53, probably by forming a complex with p53 and the Mdm2 protein (11, 12, 15) , a molecule that normally increases p53 ubiquitination and degradation (16, 17) . Signals from p19
Arf to p53 induce G 1 arrest and apoptosis in fibroblast cells and are critical for the normal senescence response (10, 13, 14, 18) . Consistent with this mechanism and the importance of p53 in tumorigenesis (reviewed in refs. 19 and 20) , mice lacking a functional p19
Arf gene develop multiple types of tumors at a high frequency (18) .
Although murine models strongly support the idea that p19
Arf is a tumor-suppressor protein, evidence for its role in naturally occurring tumors is limited. Indeed, in this arena, attention has focused on the second product of the Ink4a͞Arf locus, the p16 Ink4a cyclin-dependent kinase inhibitor (21) . This protein inhibits the activity of CDK-4 and CDK-6, suppressing their ability to phosphorylate pRb, an event that induces G 1 arrest (21) (22) (23) (24) (26) (27) (28) (29) (30) .
We investigated the role of p16
Ink4a and p19
Arf in Ab-MLV induced pre-B cell transformation to determine whether selection for Tp53 mutation involves the p19 Arf -p53 regulatory loop or whether altered expression of p16 Ink4a occurs in transformants retaining wt p53. Our studies reveal that primary transformants derived from Ink4a͞Arf Ϫ͞Ϫ mice do not undergo crisis. Because overexpression of p19 Arf , but not p16 Ink4a , induces apoptosis in a p53-dependent fashion in the transformants, these effects appear to be mediated by p19 Arf . These data identify a tumor-suppressor function for p19 Arf in Ab-MLV-induced pre-B cell transformation. Furthermore, because elevated expression of p19 Arf can precede emergence of cells harboring Tp53 mutations, high levels of p19 Arf appear to select for cells expressing mutant forms of p53.
MATERIALS AND METHODS
Cells and Mice. Ab-MLV-transformed pre-B cell lines and NIH 3T3 cells were grown as described previously (8, 31) . The pre-B cell transformants 379-10, 143-2M, and 300-31 express mutant p53, which fails to induce apoptosis after DNA damage and does not activate expression from a promoter containing p53-responsive elements (8); 298-18, 204-3-1, and 38B9 express wild-type (wt) p53 (8) . L1-2 is a p53 null cell line (32) . 379-10, 298-18, and 38B9 are transformed with Ab-MLV-P160; 143-2M, 300-31, 204-3-1, and L1-2 are transformed with Ab-MLV-P120. Both of these Ab-MLV strains are considered wild type (3) . MEL cells are murine erythroleukemic cells that express p16 Ink4a and p19 Arf (33, 34) . For isolating primary transformants, bone marrow cells were infected with Ab-MLV-P160 and plated in soft agar (9) . Primary transformants were plated in 24-well plates 10 days later in supplemented RPMI medium (RPMI 1640 medium͞2 mM L-glutamine͞50 M 2-mercaptoethanol) containing 20% fetal calf serum. When the cells filled the wells, half of them were transferred to a new well. When the viability exceeded 80%, the cells were transferred to 35-mm dishes and subcultured as before. When the cells consistently maintained a viability of Ͼ90% and could be subcultured on regular schedule, they were considered established. In some experiments, pre-B transformants were treated with approximately 1,000-rad ␥-irradiation (8); cell viability was scored the following day either by visual inspection, trypan blue staining, or merocyanin 540 (MC540, Molecular Probes) staining. BALB͞cByJ and mixed background Ink4a Ϫ͞Ϫ mice (35) were bred at Tufts University.
RNA and Protein Analysis. Total RNA was prepared by using the RNeasy Mini Kit (Qiagen) and analyzed by Northern blotting (36, 37) . The p16 Ink4a exon 1␣ probe was prepared by PCR amplification of bases Arf expression plasmids, the EcoRI fragment containing the full-length p16 Ink4a cDNA from pKS-mp16 (33) or the ClaI fragment containing the full-length p19 Arf cDNA and the codons for the hemagglutinin tag from a pSR␣-based retroviral vector (10) were inserted into the pCI vector (Promega). Before transfection, the cells were washed twice in unsupplemented RPMI 1640 and mixed with the p16 Ink4a or p19 
RESULTS

p16
Ink4a and p19 Arf Are Expressed in Transformants Expressing Mutant Tp53. To determine whether a correlation between expression of the Ink4a͞Arf locus and Tp53 status exists in Ab-MLV transformed pre-B cells, their expression was examined in a panel of transformants with known Tp53 status (8) . Northern analysis revealed that a p53-null cell line (32) and two of the three cell lines expressing mutant p53 expressed readily detectable levels of both RNAs (Fig. 1A) . Both RNAs could be detected in samples from Mut3 on prolonged exposure at levels about 10-to 20-fold less than those in Mut1. None of the cell lines expressing wt p53 expressed high levels of both p16 Ink4a and p19
Arf . Wt2 expressed abundant p16 Ink4a RNA, but p19 Arf RNA was detectable only on prolonged exposure at about 50-fold-lower levels. Wt1 lacked detectable p16 Ink4a RNA, but prolonged exposures revealed about 50-fold-less p19 Arf RNA than found in strongly positive samples; Wt3 expressed about 10-fold-less p16 Ink4a RNA than the highly positive samples but lacked detectable p19 Arf RNA. Western analyses revealed that cells expressing abundant Ink4a͞Arf locus RNAs expressed readily detectable levels of the corresponding proteins (Fig. 1B) (8) . Because the loss of p53 that often accompanies fibroblast cell immortalization is preceded by changes in Ink4a͞Arf locus expression (14, 18, 35) , we examined primary transformants for expression of Ink4a͞Arf locus products and acquisition of Tp53 mutations. None of 10 primary transformants, including the representatives shown ( Fig. 2A) , expressed detectable levels of p16 To determine whether any of these cells expressed mutant p53, the susceptibility of the cells to ␥-irradiation-induced apoptosis was monitored as soon as the cells emerged from crisis. Our earlier work has shown a strong correlation between resistance to radiation-induced apoptosis and Tp53 mutation in Ab-MLV-transformed pre-B cells (8) . By 60 days, all eight of the p16 Ink4a ͞p19
Arf -positive cell lines expressed mutant p53 as judged by resistance to irradiation-induced apoptosis; in contrast, all of the other cell lines, including one that expressed only p16
Ink4a
, underwent rapid apoptosis after irradiation (data not shown). Comparison of the times at which abundant expression of Ink4a͞Arf locus products occurred and Tp53 mutations were detected revealed that p16
Ink4a ͞p19
Arf expression became evident 10-14 days before Tp53 mutation appeared in four instances (Fig. 3, samples 1-4) . In four other cases, none of the available samples distinguished a temporal order for these changes (represented by sample 6, Fig. 3 ). However, there were no cases in which Tp53 mutation occurred before abundant expression of Ink4a͞Arf locus products. These data suggest that Ink4a͞Arf locus products play a key role in the crisis period that characterizes the transformation process and that their expression can precede and may select for mutation in Tp53.
Primary Pre-B Cell Transformants from Ink4a͞Arf ؊͞؊ Mice Bypass Crisis. To test the hypothesis that Ink4a͞Arf locus products play a role in crisis induction, the outgrowth of primary transformants from BALB͞c mice and Ink4a͞Arf Ϫ͞Ϫ mice (35) was compared. In both cases, the primary transformants contained Ͼ90% viable cells when they were explanted from agar. As expected based on analyses of primary transformants from several strains of inbred mice (I.U., A.R., and N.R., unpublished data and our unpublished data), a high percentage of the cells in all 48 primary transformants from wild-type mice underwent apoptotic crisis beginning 2-5 days after explant and continuing for about a month. MC540 staining of cells from cultures containing viable cells revealed that 50-80% of the cells showed evidence of apoptosis (Fig. 4) ; 15 of 48 primary transformants survived crisis to become established while all of the cells in the other 33 died by apoptosis during the crisis period (representatives are shown in Fig. 5 ). In contrast, none of the 48 primary transformants from Ink4a͞Arf Ϫ͞Ϫ mice underwent extensive cell death as judged by visual inspection; MC540 staining indicated that fewer than 30% of the cells in these samples showed evidence of apoptosis (Fig. 4) . These cells grew exponentially, becoming fully established in less than 10 days (representatives are shown in Fig. 5 (35) . To determine the effect of each protein on Ab-MLV-transformed pre-B cells, vectors expressing them were introduced into cells with known p53 status. The plasmids were mixed at a 5-fold excess with a plasmid encoding GFP-spectrin (39) and introduced into the cells by electroporation. GFP-spectrin is re -FIG. 3 . Up-regulation of p16 Ink4a and p19 Arf occurs as cells emerge from crisis, often before p53 mutation. p16 Ink4a and p19 Arf expression was analyzed by Western blotting, with day 0 being the day cells were removed from agar. p53 status was monitored by induction of apoptosis after ␥-irradiation (8) . The data shown are representative of analyses of 13 primary transformants, among which 3 others had patterns similar to sample 6, and 3 others had patterns similar to sample 7. Circles, p16 Ink4a ; squares, p19 Arf ; diamonds, p53 status; open symbols, undetectable protein or wt p53; filled symbols, abundant protein or mutant p53; E, the time at which cells became established. Levels of proteins were assigned based on analyses of Western blots similar to those shown in Fig. 1B and Fig. 2B . 
DISCUSSION
Our experiments show that the Ink4a͞Arf locus plays a major role in Ab-MLV-mediated pre-B cell transformation and identify these genes as one component of the cellular defense mounted against v-Abl-mediated transformation. Unlike pre-B transformants derived from normal mice (6-9), those from Ink4a͞Arf Ϫ͞Ϫ mice bypass the crisis that characterizes the transition from primary transformant to established, fully malignant cell line. In addition, all of the primary transformants become established in a very short time. In these respects, the primary Ab-MLV transformants are similar to mouse embryo cells derived from the null animals; these fibroblasts do not senesce in vitro and give rise to a high frequency of established cell lines rapidly (10, 13, 14, 18, 35) . In addition, these cells can be transformed by a single, mitogenic oncogene such as Ras without the collaboration of immortalizing oncogenes like Myc and E1A (10, 11, 13, 14, 18, 35) . Our observations with v-abl-stimulated lymphocytes suggest that these phenomena are not unique to fibroblasts; analogous events probably are responsible for the high frequency and broad spectrum of tumors observed in Ink4a͞Arf and Arf null mice (18, 35) . The Ink4a͞Arf locus encodes two proteins, p16 Ink4a and p19 Arf , both of which have tumor-suppressor functions in appropriate settings (10, 18, 21, 30, 35, 41) . However, p19 Arf appears to be the product involved in crisis induction. The strong correlation between high levels of Ink4a͞Arf locus products and the expression of mutant p53 in our transformants mirrors results obtained with fibroblasts lacking Arf (13, 14, 18) . Overexpression of p19 Arf in cells induces apoptosis in a p53-dependent fashion while overexpression of p16 Ink4a does not significantly alter their health or cell cycle status (A.R. and N.R., unpublished data). This latter result may reflect the high levels of CDK-4 and -6 present in the cells; even when all of the p16 present is bound to these proteins, a large proportion of the CDKs remain complexed to cyclin D3 and the activity of cyclin D3 remains high (unpublished data). Finally, the observation that primary transformants from Tp53 Ϫ͞Ϫ mice fail to undergo crisis (I.U., A.R., and W.R., unpublished data) is consistent with a critical role for the recently described p19 Arf -p53 regulatory loop (13) (14) (15) .
A key event in the p19 Arf -mediated response is up-regulation of p19
Arf expression (14, 18) . In fibroblasts, overexpression of c-Myc, E1A, or probably other immortalizing oncogenes can increase p19 Arf expression, at least in part through effects on E2F transcription factors (13, 14) . The link between v-Abl expression and c-Myc activation is well established (42-45), suggesting a mechanism by which p19 Arf expression can be activated. However, about half of all primary transformants do not seem to up-regulate p19 Arf , even though activation of c-Myc appears to be an obligatory step in v-Abl-mediated transformation (42, 43, 45) . Analyses of 10 transformants that do not express abundant Ink4a͞Arf locus products reveal that all of them retain at least one copy of the Ink4a͞Arf locus. In addition, these copies usually lack evidence of methylation (A. Halgren, A.R., and N.R., unpublished data). These transformants may have defects in other cellular components required to activate expression of the locus. Interestingly, these transformants still undergo crisis, suggesting that at least one other cellular defense pathway can mediate this response.
At least some primary transformants display high levels of p19 Arf expression before cells expressing mutant p53 emerge. Because Tp53 mutations initially were detected by using resistance to radiation-induced apoptosis, survival of as few as 1-5% of the treated cells can be monitored readily. This feature and the strong correlation between resistance to radiation-induced apoptosis and mutant p53 in Ab-MLVtransformed pre-B cells (8) make it unlikely that large numbers of cells harboring mutant forms of p53 were present before their detection. These data suggest that one consequence of high p19 Arf expression is selection of cells carrying Tp53 mutations. Consistent with this idea, only 2 of 40 transformants tested express mutant p53 in the absence of high p19
Arf levels and only 1 expressed high p19 Arf and wt p53. Fibroblasts from mice heterozygous for Arf or Tp53 usually lose expression or function of one but not both of these proteins as they emerge from crisis (18) . In addition, tumor-associated mutational inactivation of p53 has not been observed in many melanomas and fibrosarcomas derived from Ink4a͞Arf null mice (ref. 41 ; L. Chin and R.A.D., unpublished observations) and occurs rarely in Arf null mice (18) . Finally, a revisited analysis of several types of human cancers showed that dual inactivation of ARF and TP53 is exceptionally rare (11).
The effects of p19
Arf expression coupled with analyses of Tp53 null mice (I.U., A.R., and N.R., unpublished data) and patterns of Tp53 mutation in Ab-MLV-transformed pre-B cells suggest a model in which v-Abl expression, through activation of c-Myc, leads to p19 Arf up-regulation. p19 Arf activates p53 (11, 12, 15) , inducing the apoptotic crisis observed in primary transformants. In parallel with these events, v-Abl expression also activates Ras, the product of a classical mitogenic oncogene (46, 47) , along with other growth-stimulatory pathways (reviewed in refs. 3 and 48) ; such signals, known to temper p53-mediated apoptosis in other settings (18, 35, (49) (50) (51) (52) , counter-balance the protective cellular response and allow some cells to survive crisis. However, as noted earlier, the p19 Arf -p53 regulatory loop does not appear to be the only mechanism by which crisis is induced in primary transformants. Identifying this alternative pathway and determining its role, along with that of the p19 Arf -p53 regulatory loop in tumor induction, represents a next step toward understanding the multistep process by which tumors arise in this and other systems.
